How to pronounce“lenzilumab”in English

value of calabos through not only lenzilumab but I expect that we could announce an acquisition for calabas to acquire new products as soon as by the

down the road but right now we're focused on lenzilumab for cmml and jmml which are like I said three-year survival is 20% most people don't don't

publicly traded company the main asset of the company is drug called lenzilumab which is a potential drug for chronic myom monocytic leukemia uh trial is

choices whatsoever so I I this system needs incentives it needs the ability to say lenzilumab even though only 2 or 3,000 people might take lenzilumab it

to reverse merge touring you know uh the goal of of acquiring calab bios was to buy this antibody lenzilumab which very few people have focused on this drug you

to take huge risks calabos needs another hundred million that I'm going to give to it so that we can develop lenzilumab for cmml people of cmml have no hope no